Zantac Lawsuits – Cancer
The Zantac lawsuits claim that Zantac can be contaminated with the cancer-causing substance N-nitrosodimethylamine (NDMA).
Goode Law Office, PLLC is now accepting clients who took Zantac and have been diagnosed with cancer. Christopher W. Goode has litigated injury cases across the country for 20 years.
On September 13, 2019, the U.S. Food and Drug Administration reported the discovery of the carcinogenic contaminant N-nitrosodimethylamine (NDMA) in Zantac (ranitidine), a common heartburn medication available in both prescription and over-the-counter versions.
Although the FDA advisory states that the level of contamination is “low,” the levels have been found to be between 3,000 and 26,000 times higher than what the agency has determined to be “safe.”
The exact cause of the NDMA contamination is still under investigation. However, during the period in which Boerhinger Ingelheim and Sano manufactured and marketed Zantac, scientific research demonstrated a clear link between ranitidine, the active ingredient in Zantac, and NDMA. Specifically, when ranitidine comes in contact with water, it creates a chemical reaction that causes the formation of NDMA.
Despite awareness of this research, the manufacturer chose not to disclose this risk to the government or to people like you.
Long-term use of Zantac can lead to:
- Bladder Cancer
- Colorectal Cancer
- Esophageal/Throat/Nasal Cancer
- Kidney (Renal) Cancer
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer
- Prostate Cancer
- Stomach Cancer
- Testicular Cancer
If you took Zantac and have been diagnosed with cancer and otherwise meet our criteria, then you are entitled to significant damages.